Response to Comments: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs

This document (A59288) is a response-to-comments / notice-of-comment-period for the LHRH Analogs LCD (DL39387) and contains only administrative dates and comment/notice period information. No clinical coverage indications, limitations, documentation requirements, or frequency limits are present in the provided text. Manual review of the full LCD DL39387 is required to extract actionable coverage criteria.

"Policy text provided contains only administrative notice of comment and notice periods for LCD DL39387 regarding LHRH Analogs and does not include clinical coverage criteria."

Sign up to see full coverage criteria, indications, and limitations.